Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31The tax expense for the year comprises current and deferred tax. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income. Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that: The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.truefalse2023-04-01falseNo description of principal activity22trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13967464 2023-04-01 2024-03-31 13967464 2022-03-10 2023-03-31 13967464 2024-03-31 13967464 2023-03-31 13967464 c:Director1 2023-04-01 2024-03-31 13967464 c:Director2 2023-04-01 2024-03-31 13967464 c:RegisteredOffice 2023-04-01 2024-03-31 13967464 d:OfficeEquipment 2023-04-01 2024-03-31 13967464 d:OfficeEquipment 2024-03-31 13967464 d:OfficeEquipment 2023-03-31 13967464 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 13967464 d:CurrentFinancialInstruments 2024-03-31 13967464 d:CurrentFinancialInstruments 2023-03-31 13967464 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 13967464 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 13967464 d:ShareCapital 2024-03-31 13967464 d:ShareCapital 2023-03-31 13967464 d:RetainedEarningsAccumulatedLosses 2024-03-31 13967464 d:RetainedEarningsAccumulatedLosses 2023-03-31 13967464 c:OrdinaryShareClass1 2023-04-01 2024-03-31 13967464 c:OrdinaryShareClass1 2024-03-31 13967464 c:OrdinaryShareClass2 2023-04-01 2024-03-31 13967464 c:OrdinaryShareClass2 2024-03-31 13967464 c:OrdinaryShareClass3 2023-04-01 2024-03-31 13967464 c:OrdinaryShareClass3 2024-03-31 13967464 c:OrdinaryShareClass4 2023-04-01 2024-03-31 13967464 c:OrdinaryShareClass4 2024-03-31 13967464 c:FRS102 2023-04-01 2024-03-31 13967464 c:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13967464 c:FullAccounts 2023-04-01 2024-03-31 13967464 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13967464 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-04-01 2024-03-31 13967464 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-03-31 13967464 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-03-31 13967464 2 2023-04-01 2024-03-31 13967464 e:PoundSterling 2023-04-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 13967464









NORWICH RESPIRATORY LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
NORWICH RESPIRATORY LTD
 
 
COMPANY INFORMATION


Directors
Dr A V Kamath 
S A Kamath 




Registered number
13967464



Registered office
7 The Close

Norwich

Norfolk

NR1 4DJ




Accountants
MA Partners LLP
Chartered Accountants

7 The Close

Norwich

Norfolk

NR1 4DJ





 
NORWICH RESPIRATORY LTD
 

CONTENTS



Page
Accountants' report
 
 
1
Balance sheet
 
 
2 - 3
Notes to the financial statements
 
 
4 - 8


 
NORWICH RESPIRATORY LTD
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF NORWICH RESPIRATORY LTD
FOR THE YEAR ENDED 31 MARCH 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Norwich Respiratory Ltd for the year ended 31 March 2024 which comprise  the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the Board of directors of Norwich Respiratory Ltd, as a body, in accordance with the terms of our engagement letter dated 23 March 2022Our work has been undertaken solely to prepare for your approval the financial statements of Norwich Respiratory Ltd and state those matters that we have agreed to state to the Board of directors of Norwich Respiratory Ltd, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Norwich Respiratory Ltd and its Board of directors, as a body, for our work or for this report. 

It is your duty to ensure that Norwich Respiratory Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Norwich Respiratory Ltd. You consider that Norwich Respiratory Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Norwich Respiratory Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  





MA Partners LLP
 
Chartered Accountants
  
7 The Close
Norwich
Norfolk
NR1 4DJ

15 November 2024
Page 1

 
NORWICH RESPIRATORY LTD
REGISTERED NUMBER: 13967464

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
1,049
562

  
1,049
562

Current assets
  

Debtors: amounts falling due within one year
 5 
4,881
5,799

Cash at bank and in hand
  
51,763
32,483

  
56,644
38,282

Creditors: amounts falling due within one year
 6 
(19,882)
(12,109)

Net current assets
  
 
 
36,762
 
 
26,173

Total assets less current liabilities
  
37,811
26,735

Provisions for liabilities
  

Deferred tax
  
(200)
(107)

  
 
 
(200)
 
 
(107)

Net assets
  
37,611
26,628


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
37,511
26,528

  
37,611
26,628


Page 2

 
NORWICH RESPIRATORY LTD
REGISTERED NUMBER: 13967464
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 15 November 2024.






Dr A V Kamath
Director

The notes on pages 4 to 8 form part of these financial statements.

Page 3

 
NORWICH RESPIRATORY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

The Company is a private company limited by shares.  It is both incorporated and domiciled in England and Wales.  The address of its registered office is 7 The Close, Norwich, Norfolk, NR1 4DJ.
The Company's principal place of business is Norwich and the Company’s principal activity is that of consultant respiratory medical services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is measured at the fair value of the consideration received or receivable.  Revenue for consultant respiratory medical services is recognised in the period in which the services are provided.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
NORWICH RESPIRATORY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. The current income tax charge is  calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the  balance sheet date in the countries where the Company operates and generates income.
Deferred tax balances are recognised in respect of all timing differences that have originated but not  reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted  by the balance sheet date.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 5

 
NORWICH RESPIRATORY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors.
Debt instruments that are payable or receivable within one year, typically trade debtors and  creditors, are measured at the undiscounted amount of the cash or other consideration expected to be paid or received. 

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).

Page 6

 
NORWICH RESPIRATORY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2023
749


Additions
899



At 31 March 2024

1,648



Depreciation


At 1 April 2023
187


Charge for the year on owned assets
412



At 31 March 2024

599



Net book value



At 31 March 2024
1,049



At 31 March 2023
562


5.


Debtors

2024
2023
£
£


Trade debtors
4,881
1,920

Other debtors
-
3,869

Called up share capital not paid
-
10

4,881
5,799


Page 7

 
NORWICH RESPIRATORY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
7,493
8,066

Other creditors
9,272
-

Accruals and deferred income
3,117
4,043

19,882
12,109



7.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



40 A Ordinary shares of £1.00 each
40
40
40 B Ordinary shares of £1.00 each
40
40
10 C Ordinary shares of £1.00 each
10
10
10 D Ordinary shares of £1.00 each
10
10

100

100



8.


Transactions with directors

As at 1 April 2023, the directors owed the Company £3,869.  
During the period the directors made net repayments of £11,751 to the Company. As at 31 March 2024 the Company owed the directors 
£7,882.  The loan is included within other creditors in note 6 to the financial statements.

 
Page 8